EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis
Authors:
Open Access
- 2 December 2024
- journal article
- research article
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 56 (12) , 2673-2689
Abstract
Kidney fibrosis causes irreversible structural damage in chronic kidney disease and is characterized by aberrant extracellular matrix (ECM) accumulation. Although glutamyl-prolyl-tRNA synthetase 1 (EPRS1) is a crucial enzyme involved in proline-rich protein synthesis, its role in kidney fibrosis remains unclear. The present study revealed that EPRS1 expression levels were increased in the fibrotic kidneys of patients and mice, especially in fibroblasts and proximal tubular epithelial cells, on the basis of single-cell analysis and immunostaining of fibrotic kidneys. Moreover, C57BL/6 EPRS1tm1b heterozygous knockout (Eprs1+/−) and pharmacological EPRS1 inhibition with the first-in-class EPRS1 inhibitor DWN12088 protected against kidney fibrosis and dysfunction by preventing fibroblast activation and proximal tubular injury. Interestingly, in vitro assays demonstrated that EPRS1-mediated nontranslational pathways in addition to translational pathways under transforming growth factor β-treated conditions by phosphorylating SMAD family member 3 in fibroblasts and signal transducers and activators of transcription 3 in injured proximal tubules. EPRS1 knockdown and catalytic inhibition suppressed these pathways, preventing fibroblast activation, proliferation, and subsequent collagen production. Additionally, we revealed that EPRS1 caused mitochondrial damage in proximal tubules but that this damage was attenuated by EPRS1 inhibition. Our findings suggest that the EPRS1-mediated ECM accumulation induces kidney fibrosis via fibroblast activation and mitochondrial dysfunction. Therefore, targeting EPRS1 could be a potential therapeutic target for alleviating fibrotic injury in chronic kidney disease.Keywords
All Related Versions
Funding Information
- Soonchunhyang University
- Korean Nephrology Research Foundation
This publication has 53 references indexed in Scilit:
- RIPK3 causes mitochondrial dysfunction and albuminuria in diabetic podocytopathy through PGAM5-Drp1 signalingMetabolism, 2024
- Glutamyl-prolyl-tRNA synthetase (EPRS1) drives tubulointerstitial nephritis-induced fibrosis by enhancing T cell proliferation and activityKidney International, 2024
- Kidney Decellularized Extracellular Matrix Enhanced the Vascularization and Maturation of Human Kidney OrganoidsAdvanced Science, 2022
- eIF5A Functions Globally in Translation Elongation and TerminationMolecular Cell, 2017
- Mitochondrial Fission and Fusion Factors Reciprocally Orchestrate Mitophagic Culling in Mouse Hearts and Cultured FibroblastsCell Metabolism, 2015
- Understanding the origin, activation and regulation of matrix‐producing myofibroblasts for treatment of fibrotic diseaseThe Journal of Pathology, 2013
- Remnant nephron physiology and the progression of chronic kidney diseasePediatric Nephrology, 2013
- Models of chronic kidney diseaseDrug Discovery Today: Disease Models, 2010
- Halofuginone to treat fibrosis in chronic graft-versus-host disease and sclerodermaTransplantation and Cellular Therapy, 2003
- Collagen biosynthesis: A mini-review clusterMatrix Biology, 1998